WHO - AMR Global Overview and Action Planmarkovingian
Diberikan dan disampaikan pada Seminar "Cegah Resistensi Antibiotik: Demi Selamatkan Manusia", kerjasama Kemenkes, WHO, dan Yayasan Orang Tua Peduli, didukung oleh React, 5 Agustus 2015
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
Antibiotic stewardship explained in one presentation, which can be helpful to the medical field beginners and students as well as thorough information can be obtained regarding the subject matter.
Objectives:
1. To understand the purpose of implementing an antimicrobial stewardship program (ASP)
2.To recall the core elements of hospital and outpatient antibiotic stewardship programs as defined by the CDC
3. To recognize key interventions that an antimicrobial stewardship program can implement in both the hospital and community settings
Antibiotic policy and trends in antibiotic policy,
References
Infection control: Basic concepts and practices, 2nd edn.
www.cdc.org
Antibiotics guide: choices for common infections
Chennai Declaration
Role of PK PD in Antibiotic Stewardship Program with case study. This presentation gives an comprehensive overview about role of PK PD in antibiotic stewardship program.
WHO - AMR Global Overview and Action Planmarkovingian
Diberikan dan disampaikan pada Seminar "Cegah Resistensi Antibiotik: Demi Selamatkan Manusia", kerjasama Kemenkes, WHO, dan Yayasan Orang Tua Peduli, didukung oleh React, 5 Agustus 2015
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
Antibiotic stewardship explained in one presentation, which can be helpful to the medical field beginners and students as well as thorough information can be obtained regarding the subject matter.
Objectives:
1. To understand the purpose of implementing an antimicrobial stewardship program (ASP)
2.To recall the core elements of hospital and outpatient antibiotic stewardship programs as defined by the CDC
3. To recognize key interventions that an antimicrobial stewardship program can implement in both the hospital and community settings
Antibiotic policy and trends in antibiotic policy,
References
Infection control: Basic concepts and practices, 2nd edn.
www.cdc.org
Antibiotics guide: choices for common infections
Chennai Declaration
Role of PK PD in Antibiotic Stewardship Program with case study. This presentation gives an comprehensive overview about role of PK PD in antibiotic stewardship program.
Infection Control and Antibiotic Stewardship Symposia presented in Milot, Haiti at Hôpital Sacré Coeur.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
The beginning of a checklist version of the CMMI guidelines. If you would like the original Excel version let me know, and let SlideShare know they need to support Excel files.
Antimicrobial stewardship programs (ASP) are an essential practice to prevent increasing
resistance against antibiotics. A successful ASP monitors not only prescribing patterns and
practices but also contributes in minimizing the toxic effects of antibiotics. Moreover, ASP
also facilitates the selection of disease specific antibiotics and enforces rules and regulations to rationalize the use of antibiotics. The aim of the study is to highlight the core
elements of Hospital Antibiotic Stewardship Programs in Karachi. The key elements proposed by center of disease control (CDC) such as; leadership, accountability, drug
expertise, actions to support optimal antibiotic use, tracking (monitoring antibiotic prescribing, use and resistance), reporting information to staff on improving antibiotic use
and resistance and education were evaluated on Yes/No scale. The data was collected
from 44 hospitals of different categories in Karachi and all the major elements were
studied. It was observed that all the hospitals in one setting failed to comply with all the
guidelines. It has been concluded that efforts should be made to design ASP at each
hospital and implemented through suitable policies and procedures.
Role and Responsibilties of ICD IN abx.pptxShahnazAlman2
Infection prevention and control (IP&C) practices are important in maintaining a safe environment for everyone by reducing the risk of the potential spread of disease.
Dr. Jeff Bender - Companion Animal Antimicrobial StewardshipJohn Blue
Companion Animal Antimicrobial Stewardship - Dr. Jeff Bender, Co-Director for the Upper Midwest Agricultural Safety and Health Center and Professor College of Veterinary Medicine and School of Public Health at the University of Minnesota, Chair for the AVMA Task Force for Antimicrobial Stewardship in companion Animal Practice, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...John Blue
Antimicrobial Stewardship - the State Health Department Perspective - Dr. Marion A. Kainer, Director, Healthcare Associated Infections and Antimicrobial Resistance Program, Tennessee Department of Health, from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
In today’s healthcare environment, there is an increasing emphasis on antimicrobial stewardship programs (ASP) and their impact on patient and community health and hospital financials. There are now new regulatory standards from The Joint Commission (TJC) that require hospitals to implement ASPs, and the Centers for Medicare and Medicaid Services (CMS) has proposed making it mandatory that hospitals implement an ASP in order to participate in Medicare and Medicaid. Regardless, a solid ASP is critically important to patient wellbeing, public health, and a hospital’s bottom line. This webinar will focus on how to bring a successful ASP to life in your hospital with a business plan and buy in from key stakeholders across the organization.
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health ExamplesJohn Blue
One Health Antibiotic Stewardship Human Health Examples - Dr. Dawn Sievert, Associate Director for Antimicrobial Resistance, Division of Foodborne, Waterborne, and Environmental Diseases, CDC; Dr. Edward J. Septimus, V.P. Research & Infectious Diseases, Hospital Corporation of America; Dr. Lauri Hicks, Director, Office of Antibiotic Stewardship, CDC, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Similar to Antimicrobial stewardship program_checklist (20)
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
1. Step and Description Clinical Decision Support System Requirements for Each Step
1. Vaccinate Vaccination reminders
2. Remove catheters Catheter extended-use alerts
Drug-bug mismatch alerts
Drug spectrum alerts
Infer infections
Timing-of-therapy alerts
Timing-of-prophylaxis alerts
Drug dosage alerts
4. Access the experts Recommend infectious disease consulations when appropriate
Parenteral-to-oral switch alerts
Automated formulary checking
Automated recommendations for prophylaxis
Evidence-based knowledge bases
Automated antibiograms
Automated empiric recommendations
Track and alert on emerging resistance
7. Treat infection, not contamination Infer contamination of specimens
8. Treat infection, not colonization Infer colonization
9. Know when to say no to vancomycin Target-drug alerts
Duration-of-therapy alerts
Duration-of-prophylaxis alerts
Patient isolation alerts
Infection control precaution reminders
Healthcare-associated infections case-finding alerts
Patient-based location tracking
Clonal detection and alerting
Target-organism alerts
Handwashing reminders
Online infection control information
6. Use local data
10. Stop treatment when infection is cured or unlikely
PREVENT TRANSMISSION
11. Isolate the pathogen
12. Break the chain of contagion
Adapted from CDC "12-steps to prevent antimicrobial resistance among hospitalized adults"
http://www.cdc.gov/drugresistance/healthcare/ha/haslideset.pdf (no longer available online); superceded by the
"Core Elements of Hospital Antibiotic Stewardship Programs"
http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.pdf
PREVENT INFECTIONS
DIAGNOSE AND TREAT INFECTIONS EFFECTIVELY
3. Target the pathogen
USE ANTIMICROBIALS WISELY
5. Practice antimicrobial control
2. Checklist for Core Elements of Hospital Antiobiotic Stewardship Programs
LEADERSHIP SUPPORT
ESTABLISHED AT
FACILITY
A. Does your facility have a formal, written statement of support from
leadership that supports efforts to improve antibiotic use (antibiotic
stewardship)?
❑ Yes ❑ No
B. Does your facility receive any budgeted financial support for antibiotic
stewardship activities (e.g., support for salary, training, or IT support)?
❑ Yes ❑ No
A. Is there a physician leader responsible for program outcomes of
stewardship activities at your facility?
❑ Yes ❑ No
A. Is there a pharmacist leader responsible for working to improve antibiotic
use at your facility?
❑ Yes ❑ No
B. Clinicians ❑ Yes ❑ No
C. Infection Prevention and Healthcare Epidemiology ❑ Yes ❑ No
D. Quality Improvement ❑ Yes ❑ No
E. Microbiology (Laboratory) ❑ Yes ❑ No
F. Information Technology (IT) ❑ Yes ❑ No
G. Nursing ❑ Yes ❑ No
ACTIONS TO SUPPORT OPTIMAL ANTIBIOTIC USE
POLICY
ESTABLISHED
A. Does your facility have a policy that requires prescribers to document in the
medical record or during order entry a dose, duration, and indication for all
antibiotic prescriptions?
❑ Yes ❑ No
B. Does your facility have facility-specific treatment recommendations, based
on national guidelines and local susceptibility, to assist with antibiotic selection
for common clinical conditions?
❑ Yes ❑ No
Checklist for Core Elements of Hospital Antibiotic Stewardship Programs
http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.pdf
ACCOUNTABILITY
DRUG EXPERTISE
KEY SUPPORT FOR THE ANTIBIOTIC STEWARDSHIP PROGRAM
Page 2 of 5
3. Checklist for Core Elements of Hospital Antiobiotic Stewardship Programs
BROAD INTERVENTIONS
ACTION
PERFORMED
C. Is there a formal procedure for all clinicians to review the appropriateness
of all antibiotics 48 hours after the initial orders (e.g. antibiotic time out)?
❑ Yes ❑ No
D. Do specified antibiotic agents need to be approved by a physician or
pharmacist prior to dispensing (i.e., pre-authorization) at your facility?
❑ Yes ❑ No
E. Does a physician or pharmacist review courses of therapy for specified
antibiotic agents (i.e., prospective audit with feedback) at your facility?
❑ Yes ❑ No
PHARMACY-DRIVEN INTERVENTIONS
Are the following actions implemented in your facility?
ACTION
PERFORMED
F. Automatic changes from intravenous to oral antibiotic therapy in appropriate
situations?
❑ Yes ❑ No
G. Dose adjustments in cases of organ dysfunction? ❑ Yes ❑ No
H. Dose optimization (pharmacokinetics/pharmacodynamics) to optimize the
treatment of organisms with reduced susceptibility?
❑ Yes ❑ No
I. Automatic alerts in situations where therapy might be unnecessarily
duplicative?
❑ Yes ❑ No
J. Time-sensitive automatic stop orders for specified antibiotic prescriptions? ❑ Yes ❑ No
SPECIFIC INTERVENTIONS TO IMPROVE ANTIBIOTIC USE
Page 3 of 5
4. Checklist for Core Elements of Hospital Antiobiotic Stewardship Programs
DIAGNOSIS AND INFECTIONS SPECIFIC INTERVENTIONS
Does your facility have specific interventions in place to ensure optimal
use of antibiotics to treat the following common infections?
ACTION
PERFORMED
K. Community-acquired pneumonia ❑ Yes ❑ No
L. Urinary tract infection ❑ Yes ❑ No
M. Skin and soft tissue infections ❑ Yes ❑ No
N. Surgical prophylaxis ❑ Yes ❑ No
O. Empiric treatment of Methicillin-resistant Staphylococcus aureus (MRSA) ❑ Yes ❑ No
P. Non-C. Difficile infection (CDI) antibiotics in new cases of CDI ❑ Yes ❑ No
Q. Culture-proven invasive (e.g., blood stream) infections ❑ Yes ❑ No
PROCESS MEASURES
MEASURE
PERFORMED
A. Does your stewardship program monitor adherence to a documentation
policy (dose, duration, and indication)?
❑ Yes ❑ No
B. Does your stewardship program monitor adherence to facility-specific
treatment recommendations?
❑ Yes ❑ No
C. Does your stewardship program monitor compliance with one of more of
the specific interventions in place?
❑ Yes ❑ No
ANTIBIOTIC USE AND OUTCOME MEASURES
MEASURE
PERFORMED
D. Does your facility track rates of C. difficile infection? ❑ Yes ❑ No
E. Does your facility produce an antibiogram (cumulative antibiotic
susceptibility report?
❑ Yes ❑ No
Does your facility monitor antibiotic use (consumption) at the unit and/or
facility wide level by one of the following metrics:
MEASURE
PERFORMED
F. By counts of antibiotic(s) administered to patients per day (Days of Therapy;
DOT)?
❑ Yes ❑ No
G. By number of grams of antibiotics used (Defined Daily Dose, DDD)? ❑ Yes ❑ No
H. By direct expenditure for antibiotics (purchasing costs)? ❑ Yes ❑ No
TRACKING: MONITORING ANTIBIOTIC PRESCRIBING, USE, AND RESISTANCE
Page 4 of 5
5. Checklist for Core Elements of Hospital Antiobiotic Stewardship Programs
A. Does you stewardship program share facility-specific reports on antibiotic
use with prescribers?
❑ Yes ❑ No
B. Has a current antibiogram been distributed to prescribers at your facility? ❑ Yes ❑ No
C. Do prescribers ever receive direct, personalized communication about how
they can improve their antibiotic prescribing?
❑ Yes ❑ No
A. Does your stewardship program provide education to clinicians and other
relevant staff on improving antibiotic prescribing?
❑ Yes ❑ No
REPORTING INFORMATION TO STAFF ON IMPROVING ANTIBIOTIC USE AND RESISTANCE
EDUCATION
Page 5 of 5